BioCorRx Inc.
BICX
$0.2866
-$0.2034-41.51%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | -- | 4.00K | 3.60K | 18.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | -- | 4.00K | 3.60K | 18.90K |
| Cost of Revenue | 0.00 | -- | -- | 1.70K | 13.10K |
| Gross Profit | 0.00 | -- | 4.00K | 2.00K | 5.90K |
| SG&A Expenses | 839.20K | 1.19M | 830.30K | 750.10K | 693.60K |
| Depreciation & Amortization | 13.00K | 6.70K | 6.70K | 6.70K | 6.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.12M | 1.66M | 1.37M | 972.30K | 841.70K |
| Operating Income | -1.12M | -1.66M | -1.37M | -968.70K | -822.70K |
| Income Before Tax | -1.23M | -1.51M | -1.23M | -1.24M | -969.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.23M | -1.51M | -1.23M | -1.24M | -969.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 63.00K | 25.60K | 16.70K | 700.00 | 500.00 |
| Net Income | -1.16M | -1.49M | -1.22M | -1.24M | -968.50K |
| EBIT | -1.12M | -1.66M | -1.37M | -968.70K | -822.70K |
| EBITDA | -1.11M | -1.65M | -1.36M | -962.00K | -816.00K |
| EPS Basic | -0.09 | -0.14 | -0.13 | -0.14 | -0.11 |
| Normalized Basic EPS | -0.05 | -0.08 | -0.08 | -0.09 | -0.07 |
| EPS Diluted | -0.09 | -0.14 | -0.13 | -0.14 | -0.11 |
| Normalized Diluted EPS | -0.05 | -0.08 | -0.08 | -0.09 | -0.07 |
| Average Basic Shares Outstanding | 12.72M | 10.91M | 9.46M | 8.76M | 8.62M |
| Average Diluted Shares Outstanding | 12.72M | 10.91M | 9.46M | 8.76M | 8.62M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |